Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy.
作者信息
Mauldin Ileana Soto, Minnar Christine Mall, Italiano Antoine
机构信息
Department of Surgery, University of Virginia Health System, Charlottesville, VA, United States.
Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
出版信息
Front Immunol. 2025 Apr 7;16:1591820. doi: 10.3389/fimmu.2025.1591820. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy.社论：免疫治疗期间肿瘤相关三级淋巴结构反应
Front Immunol. 2025 Apr 7;16:1591820. doi: 10.3389/fimmu.2025.1591820. eCollection 2025.
2
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer.肿瘤和基质 hMENA 异构体影响肺癌中三级淋巴结构的定位，并预测癌症患者免疫检查点阻断反应。
EBioMedicine. 2024 Mar;101:105003. doi: 10.1016/j.ebiom.2024.105003. Epub 2024 Feb 9.
3
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma.三级淋巴结构的空间特征作为头颈部鳞状细胞癌免疫检查点阻断的预测生物标志物
Oncoimmunology. 2025 Dec;14(1):2466308. doi: 10.1080/2162402X.2025.2466308. Epub 2025 Feb 18.
4
Multiple mechanisms and applications of tertiary lymphoid structures and immune checkpoint blockade.三级淋巴结构和免疫检查点阻断的多种机制及应用
J Exp Clin Cancer Res. 2025 Mar 5;44(1):84. doi: 10.1186/s13046-025-03318-6.
5
HLA-A tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma.在食管鳞状细胞癌中，与免疫治疗反应阳性相关的是 HLA-A 三级淋巴结构伴再激活的肿瘤浸润淋巴细胞。
Br J Cancer. 2024 Jul;131(1):184-195. doi: 10.1038/s41416-024-02712-9. Epub 2024 May 18.
6
Tumor-Associated Tertiary Lymphoid Structures: A Cancer Biomarker and a Target for Next-generation Immunotherapy.肿瘤相关三级淋巴结构：下一代免疫疗法的癌症生物标志物和靶点。
Adv Exp Med Biol. 2021;1329:51-68. doi: 10.1007/978-3-030-73119-9_3.
7
Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck Cancer.免疫细胞密度可预测头颈癌对免疫检查点阻断疗法的反应。
medRxiv. 2024 Sep 12:2024.09.10.24313432. doi: 10.1101/2024.09.10.24313432.
8
Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.肿瘤内三级淋巴结构可提高头颈部鳞状细胞癌患者的生存率和免疫治疗反应。
Cancer Immunol Immunother. 2023 Jun;72(6):1505-1521. doi: 10.1007/s00262-022-03310-5. Epub 2022 Dec 8.
9
Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV HNSCC.三级淋巴结构可提高 HPV-HNSCC 的生存率和免疫治疗效果。
J Dent Res. 2023 Jun;102(6):678-688. doi: 10.1177/00220345231151685. Epub 2023 Mar 8.
10
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.三级淋巴结构标志物 CXCL13 与接受免疫治疗的晚期膀胱癌患者的生存改善相关。
Eur J Cancer. 2021 May;148:181-189. doi: 10.1016/j.ejca.2021.01.036. Epub 2021 Mar 18.
本文引用的文献
1
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside.三级淋巴结构与癌症免疫疗法：从实验台到病床旁
Med. 2025 Jan 10;6(1):100546. doi: 10.1016/j.medj.2024.10.023.
2
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.成熟的三级淋巴结构可独立于PD-L1表达预测实体瘤中免疫检查点抑制剂的疗效。
Nat Cancer. 2021 Aug;2(8):794-802. doi: 10.1038/s43018-021-00232-6. Epub 2021 Aug 12.
Zotero 插件